Literature DB >> 10347994

Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.

A Nakad, L Bataille, V Hamoir, C Sempoux, Y Horsmans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347994     DOI: 10.1016/S0140-6736(99)00569-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Authors:  Anita Conforti; Lara Magro; Ugo Moretti; Stefania Scotto; Domenico Motola; Francesco Salvo; Barbara Ros; Roberto Leone
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

Authors:  H S Malhotra; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Statin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman.

Authors:  Jimmy Jose; Faisal Abdullah Ali Al-Tamimi; Manal Mahmoud Helal; Beena Jimmy; Qasim Al Riyami
Journal:  Oman Med J       Date:  2014-09

5.  Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin.

Authors:  Y Liu; Z Cheng; L Ding; F Fang; K-A Cheng; Q Fang; G-P Shi
Journal:  Int J Clin Pharmacol Ther       Date:  2010-12       Impact factor: 1.366

6.  Atorvastatin-induced severe gastric ulceration: a case report.

Authors:  Ihab I El-Hajj; Fadi H Mourad; Nina S Shabb; Kassem A Barada
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 7.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

Review 8.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

9.  Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Authors:  Mark W Russo; Jay H Hoofnagle; Jiezhun Gu; Robert J Fontana; Huiman Barnhart; David E Kleiner; Naga Chalasani; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2014-05-13       Impact factor: 17.425

10.  A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.

Authors:  Biswas Gopa; Jagatkumar Bhatt; Kovur G Hemavathi
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.